End Stage Renal Disease. End-stage Renal Disease
Conditions
Interventions
Intervention 1: Remifentanil and Propofol with target controlled method. Intervention 2: IV induction with Sufentanil and Propofol and inhalational anesthesia with isoflurane and N2O for maintenance.
Treatment - Drugs
Remifentanil and Propofol with target controlled method
IV induction with Sufentanil and Propofol and inhalational anesthesia with isoflurane and N2O for maintenance
Sponsors
Pro-vice-chancellor for Research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 18-60 years, ASA class II-III, End Stage Renal Disease candidate for renal transplantation Exclusion criteria: ASA class more than III, denial of patients, any dependence to opioids or sedative agents.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vital signs during renal transplantation surgery. Timepoint: T1: before induction of anesthesia, T2: immediately after intubation, T3: after skin incision, T4: before declamping renal artery, T5: after skin suture, T6: after extubation, T7: in the recovery room. Method of measurement: Clinical examination and non-invasive blood pressure measurement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and Vomiting. Timepoint: every 2 h in first 24 h after operation. Method of measurement: observation,clinical examination.;Pain. Timepoint: Every 2 hour during 24 hours after operation. Method of measurement: visual analoge scale.;Urine output. Timepoint: Every 2 hour during 24 hours after operation. Method of measurement: Volume of urine output per hour. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaser Yeganeh
Imam Reza Hospital
Outcome results
None listed